What are the approved uses for Wegovy / Wegovy HD and Zepbound
Evidence-based approacheslike therapy, lifestyle adjustments, and, when appropriate, medications prescribed after a professional evaluationare safer and more effective for lasting relief
This regulatory difference is why compounded formulations carry BUDs rather than expiration dates, and why those BUDs tend to be shorter
Results do vary, but in a 68-week medical study of 1,961 adults living with obesity or excess weight with a related medical problem, adults lost ~35 lbs (or ~15% body weight)
In the UK, Wegovy (semaglutide 2.4 mg weekly) is licensed specifically for weight management in adults with obesity or overweight with weight-related comorbidities, subject to NICE criteria (TA875)
GLP-1 medications often lead to : - Rapid weight loss - Significant muscle loss - Metabolic slowdown : True fat loss, on the other hand True fat loss, on the other hand - Preserves lean muscle - Supports metabolic health - Improves body composition - Is far more sustainable The Long-Term Risk Most People Arent Told About When muscle mass is lost : - Blood sugar control worsens over time - Insulin sensitivity can decline - Functional strength decreases - Risk of injury increases - Quality of life declines with age Ironically, the very medications designed to improve metabolic health may undermine it long term if muscle loss is not addressed